• Home
  • /Archive by category ' Business '

Archive For: Business

US AFTER FINAL CONSIDERATION PILOT (AFCP) PROGRAM FLOPPED

US AFTER FINAL CONSIDERATION PILOT (AFCP) PROGRAM FLOPPED

Just recently we issued a paper concerning drawbacks of US patent prosecution (see our previous blogs) and now JURISTAT published a new analysis on the After Final Consideration Pilot (AFCP) 2.0. In 2013, USPTO enacted the program as an alternative response to a final rejection. The goal of the program was to increase communication between ... Read More
 
DAVID VS GOLIATH – LANDMARK DECISION ON TRADEMARKS AS PILOTS

DAVID VS GOLIATH – LANDMARK DECISION ON TRADEMARKS AS PILOTS

In the legal dispute between the bicycle bag manufacturer ORTLIEB and AMAZON, the German Supreme Court (BGH) has now handed down a landmark decision and Ortlieb has long defended itself against the practice that when customers enter „Ortlieb bicycle bags“, they end up at Amazon, where they are also shown other offers from other manufacturers, ... Read More
 
LUNES DE PATENTES

LUNES DE PATENTES

At the invitation of Prof. Pascual SEGURA, Professor at the UB Patent Center of the University of Barcelona, Bernd FABRY, CEO of IP2 Patentanwalts GmbH, gave around 80 lawyers and law students an overview of German employee invention law at the „Lunes de Patentes“ event, in particular with regard to employer obligations, inventors compensation and ... Read More
 
NEYMAR GOT HIS NAME BACK

NEYMAR GOT HIS NAME BACK

With the good name of sport stars, good money can still be earned – even if this takes place in the grey area of the legally permissible. Boris Becker can sing a song about it and now the Brazilian superstar Neymar has had to learn how quickly the right to his own name can be ... Read More
 
SWITZERLAND CREATES NEW EXTENSION FOR SPC

SWITZERLAND CREATES NEW EXTENSION FOR SPC

Supplemental Protection Certificates (SPC) can extend a patent right for a maximum of five years. A six-month additional extension is available in accordance with Regulation (EC) No 1901/2006 if the SPC relates to a medicinal product for children for which data has been submitted according to a Pediatric Investigation Plan (PIP). PIPs are required to ... Read More
 
CHINA: NEW DEVELOPMENTS FOR PHARMACEUTICAL PATENTS

CHINA: NEW DEVELOPMENTS FOR PHARMACEUTICAL PATENTS

Ticagrelor (trade name Brilinta, Brilique, and Possia) is a blockbuster drug produced by AstraZeneca with total sales of $1,079m in 2017. Ticagrelor: is a platelet aggregation inhibitor and is used for the prevention of thrombotic events (for example stroke or heart attack) in people with acute coronary syndrome or myocardial infarction with ST elevation. 
 
PORSCHE BACK IN COURT AGAIN

PORSCHE BACK IN COURT AGAIN

The involvement in the diesel exhaust scandal is currently not the only legal worksite with which Germany’s prominent carmaker Porsche has to deal. Last week, the District Court Stuttgart advised on the admissibility of a lawsuit filed by Ingrid Steineck, the daughter of former Porsche chief designer Erwin Komenda.